| Literature DB >> 25598992 |
Pietro Giudice, Tiziana Attisano, Marco Di Maio, Elisabetta M Bellino, Maria V Polito, Cesare Baldi, Francesco Vigorito, Michele R Di Muro, Salvatore D Tomasello, Alfredo R Galassi, Federico Piscione.
Abstract
First generation drug-eluting stent can cause a paradoxical "in-segment" coronary vasoconstriction. This phenomenon was seen with sirolimus, paclitaxel, and, more recently, also with zotarolimus-eluting stent. For the first time, we describe a case of coronary-induced vasoconstriction by everolimus-eluting stents (EES).Entities:
Keywords: DES; coronary artery disease; coronary flow reserve; coronary spasm; everolimus-eluting stent
Year: 2014 PMID: 25598992 PMCID: PMC4274358 DOI: 10.1556/IMAS.6.2014.4.6
Source DB: PubMed Journal: Interv Med Appl Sci ISSN: 2061-1617